List of Tables
Table 1. Global Multiple Sclerosis Therapeutics Market Size Growth Rate by Type (US$ Million), 2017 VS 2021 VS 2028
Table 2. Key Players of Beta Interferon
Table 3. Key Players of Corticosteroids
Table 4. Key Players of Monoclonal Antibodies
Table 5. Key Players of Antineoplastic Agents
Table 6. Key Players of Others
Table 7. Global Multiple Sclerosis Therapeutics Market Size Growth Rate by Distribution Channel (US$ Million), 2017 VS 2021 VS 2028
Table 8. Global Multiple Sclerosis Therapeutics Market Size (US$ Million) by Region: 2017 VS 2021 VS 2028
Table 9. Global Multiple Sclerosis Therapeutics Revenue by Region (2017-2022) & (US$ Million)
Table 10. Global Multiple Sclerosis Therapeutics Revenue Market Share by Region (2017-2022)
Table 11. Global Multiple Sclerosis Therapeutics Revenue by Players (2017-2022) & (US$ Million)
Table 12. Global Multiple Sclerosis Therapeutics Market Share by Players (2017-2022)
Table 13. Global Top Multiple Sclerosis Therapeutics Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Multiple Sclerosis Therapeutics as of 2021)
Table 14. Ranking of Global Top Multiple Sclerosis Therapeutics Companies by Revenue (US$ Million) in 2021
Table 15. Global 5 Largest Players Market Share by Multiple Sclerosis Therapeutics Revenue (CR5 and HHI) & (2017-2022)
Table 16. Key Players Headquarters and Area Served
Table 17. Key Players Multiple Sclerosis Therapeutics Product Solution and Service
Table 18. Date of Key Manufacturers Enter into Multiple Sclerosis Therapeutics Market
Table 19. Mergers & Acquisitions, Expansion Plans
Table 20. Global Multiple Sclerosis Therapeutics Market Size by Type (2017-2022) & (US$ Million)
Table 21. Global Multiple Sclerosis Therapeutics Revenue Market Share by Type (2017-2022)
Table 22. Global Multiple Sclerosis Therapeutics Forecasted Market Size by Type (2023-2028) & (US$ Million)
Table 23. Global Multiple Sclerosis Therapeutics Revenue Market Share by Type (2023-2028)
Table 24. Global Multiple Sclerosis Therapeutics Market Size by Distribution Channel (2017-2022) & (US$ Million)
Table 25. Global Multiple Sclerosis Therapeutics Revenue Market Share by Distribution Channel (2017-2022)
Table 26. Global Multiple Sclerosis Therapeutics Forecasted Market Size by Distribution Channel (2023-2028) & (US$ Million)
Table 27. Global Multiple Sclerosis Therapeutics Revenue Market Share by Distribution Channel (2023-2028)
Table 28. North America Multiple Sclerosis Therapeutics Revenue by Company (2020-2022) & (US$ Million)
Table 29. North America Multiple Sclerosis Therapeutics Revenue by Type (2017-2022) & (US$ Million)
Table 30. North America Multiple Sclerosis Therapeutics Revenue by Type (2023-2028) & (US$ Million)
Table 31. North America Multiple Sclerosis Therapeutics Revenue by Distribution Channel (2017-2022) & (US$ Million)
Table 32. North America Multiple Sclerosis Therapeutics Revenue by Distribution Channel (2023-2028) & (US$ Million)
Table 33. North America Multiple Sclerosis Therapeutics Revenue by Country (2017-2022) & (US$ Million)
Table 34. North America Multiple Sclerosis Therapeutics Revenue by Country (2023-2028) & (US$ Million)
Table 35. Europe Multiple Sclerosis Therapeutics Revenue by Company (2020-2022) & (US$ Million)
Table 36. Europe Multiple Sclerosis Therapeutics Revenue by Type (2017-2022) & (US$ Million)
Table 37. Europe Multiple Sclerosis Therapeutics Revenue by Type (2023-2028) & (US$ Million)
Table 38. Europe Multiple Sclerosis Therapeutics Revenue by Distribution Channel (2017-2022) & (US$ Million)
Table 39. Europe Multiple Sclerosis Therapeutics Revenue by Distribution Channel (2023-2028) & (US$ Million)
Table 40. Europe Multiple Sclerosis Therapeutics Revenue by Country (2017-2022) & (US$ Million)
Table 41. Europe Multiple Sclerosis Therapeutics Revenue by Country (2023-2028) & (US$ Million)
Table 42. Asia Pacific Multiple Sclerosis Therapeutics Revenue by Company (2020-2022) & (US$ Million)
Table 43. Asia Pacific Multiple Sclerosis Therapeutics Revenue by Type (2017-2022) & (US$ Million)
Table 44. Asia Pacific Multiple Sclerosis Therapeutics Revenue by Type (2023-2028) & (US$ Million)
Table 45. Asia Pacific Multiple Sclerosis Therapeutics Revenue by Distribution Channel (2017-2022) & (US$ Million)
Table 46. Asia Pacific Multiple Sclerosis Therapeutics Revenue by Distribution Channel (2023-2028) & (US$ Million)
Table 47. Asia Pacific Multiple Sclerosis Therapeutics Revenue by Region (2017-2022) & (US$ Million)
Table 48. Asia Pacific Multiple Sclerosis Therapeutics Revenue by Region (2023-2028) & (US$ Million)
Table 49. Latin America Multiple Sclerosis Therapeutics Revenue by Company (2020-2022) & (US$ Million)
Table 50. Latin America Multiple Sclerosis Therapeutics Revenue by Type (2017-2022) & (US$ Million)
Table 51. Latin America Multiple Sclerosis Therapeutics Revenue by Type (2023-2028) & (US$ Million)
Table 52. Latin America Multiple Sclerosis Therapeutics Revenue by Distribution Channel (2017-2022) & (US$ Million)
Table 53. Latin America Multiple Sclerosis Therapeutics Revenue by Distribution Channel (2023-2028) & (US$ Million)
Table 54. Latin America Multiple Sclerosis Therapeutics Revenue by Country (2017-2022) & (US$ Million)
Table 55. Latin America Multiple Sclerosis Therapeutics Revenue by Country (2023-2028) & (US$ Million)
Table 56. Middle East and Africa Multiple Sclerosis Therapeutics Revenue by Company (2020-2022) & (US$ Million)
Table 57. Middle East and Africa Multiple Sclerosis Therapeutics Revenue by Type (2017-2022) & (US$ Million)
Table 58. Middle East and Africa Multiple Sclerosis Therapeutics Revenue by Type (2023-2028) & (US$ Million)
Table 59. Middle East and Africa Multiple Sclerosis Therapeutics Revenue by Distribution Channel (2017-2022) & (US$ Million)
Table 60. Middle East and Africa Multiple Sclerosis Therapeutics Revenue by Distribution Channel (2023-2028) & (US$ Million)
Table 61. Middle East and Africa Multiple Sclerosis Therapeutics Revenue by Country (2017-2022) & (US$ Million)
Table 62. Middle East and Africa Multiple Sclerosis Therapeutics Revenue by Country (2023-2028) & (US$ Million)
Table 63. Novartis Company Details
Table 64. Novartis Business Overview
Table 65. Novartis Multiple Sclerosis Therapeutics Product and Services
Table 66. Novartis Multiple Sclerosis Therapeutics Revenue in Multiple Sclerosis Therapeutics Business (2017-2022) & (US$ Million)
Table 67. Novartis Multiple Sclerosis Therapeutics SWOT Analysis
Table 68. Novartis Recent Developments
Table 69. Teva Pharmaceuticals Company Details
Table 70. Teva Pharmaceuticals Business Overview
Table 71. Teva Pharmaceuticals Multiple Sclerosis Therapeutics Product and Services
Table 72. Teva Pharmaceuticals Multiple Sclerosis Therapeutics Revenue in Multiple Sclerosis Therapeutics Business (2017-2022) & (US$ Million)
Table 73. Teva Pharmaceuticals Multiple Sclerosis Therapeutics SWOT Analysis
Table 74. Teva Pharmaceuticals Recent Developments
Table 75. Sanofi Genzyme Company Details
Table 76. Sanofi Genzyme Business Overview
Table 77. Sanofi Genzyme Multiple Sclerosis Therapeutics Product and Services
Table 78. Sanofi Genzyme Multiple Sclerosis Therapeutics Revenue in Multiple Sclerosis Therapeutics Business (2017-2022) & (US$ Million)
Table 79. Sanofi Genzyme Multiple Sclerosis Therapeutics SWOT Analysis
Table 80. Sanofi Genzyme Recent Developments
Table 81. Bayer Company Details
Table 82. Bayer Business Overview
Table 83. Bayer Multiple Sclerosis Therapeutics Product and Services
Table 84. Bayer Multiple Sclerosis Therapeutics Revenue in Multiple Sclerosis Therapeutics Business (2017-2022) & (US$ Million)
Table 85. Bayer Multiple Sclerosis Therapeutics SWOT Analysis
Table 86. Bayer Recent Developments
Table 87. Pfizer Company Details
Table 88. Pfizer Business Overview
Table 89. Pfizer Multiple Sclerosis Therapeutics Product and Services
Table 90. Pfizer Multiple Sclerosis Therapeutics Revenue in Multiple Sclerosis Therapeutics Business (2017-2022) & (US$ Million)
Table 91. Pfizer Multiple Sclerosis Therapeutics SWOT Analysis
Table 92. Pfizer Recent Developments
Table 93. Biogen Idec Company Details
Table 94. Biogen Idec Business Overview
Table 95. Biogen Idec Multiple Sclerosis Therapeutics Product and Services
Table 96. Biogen Idec Multiple Sclerosis Therapeutics Revenue in Multiple Sclerosis Therapeutics Business (2017-2022) & (US$ Million)
Table 97. Biogen Idec Multiple Sclerosis Therapeutics SWOT Analysis
Table 98. Biogen Idec Recent Developments
Table 99. Merck Company Details
Table 100. Merck Business Overview
Table 101. Merck Multiple Sclerosis Therapeutics Product and Services
Table 102. Merck Multiple Sclerosis Therapeutics Revenue in Multiple Sclerosis Therapeutics Business (2017-2022) & (US$ Million)
Table 103. Merck Multiple Sclerosis Therapeutics SWOT Analysis
Table 104. Merck Recent Developments
Table 105. AbbVie Company Details
Table 106. AbbVie Business Overview
Table 107. AbbVie Multiple Sclerosis Therapeutics Product and Services
Table 108. AbbVie Multiple Sclerosis Therapeutics Revenue in Multiple Sclerosis Therapeutics Business (2017-2022) & (US$ Million)
Table 109. AbbVie Multiple Sclerosis Therapeutics SWOT Analysis
Table 110. AbbVie Recent Developments
Table 111. Multiple Sclerosis Therapeutics Market Trends
Table 112. Multiple Sclerosis Therapeutics Market Drivers
Table 113. Multiple Sclerosis Therapeutics Market Challenges
Table 114. Multiple Sclerosis Therapeutics Market Restraints
Table 115. Research Programs/Design for This Report
Table 116. Key Data Information from Secondary Sources
Table 117. Key Data Information from Primary Sources
List of Figures
Figure 1. Global Multiple Sclerosis Therapeutics Sales Market Share by Type: 2021 VS 2028
Figure 2. Beta Interferon Features
Figure 3. Corticosteroids Features
Figure 4. Monoclonal Antibodies Features
Figure 5. Antineoplastic Agents Features
Figure 6. Others Features
Figure 7. Global Multiple Sclerosis Therapeutics Sales Market Share by Distribution Channel: 2021 VS 2028
Figure 8. Hospital Pharmacies Case Studies
Figure 9. Retail Pharmacies Case Studies
Figure 10. e-Commerce Case Studies
Figure 11. Multiple Sclerosis Therapeutics Report Years Considered
Figure 12. Global Multiple Sclerosis Therapeutics Revenue, (US$ Million), 2017 VS 2021 VS 2028
Figure 13. Global Multiple Sclerosis Therapeutics Market Size 2017-2028 (US$ Million)
Figure 14. Global Multiple Sclerosis Therapeutics Market Size Market Share by Region: 2021 VS 2028
Figure 15. Global Multiple Sclerosis Therapeutics Revenue Market Share by Region in 2017 VS 2022
Figure 16. Global Top 10 Multiple Sclerosis Therapeutics Countries Ranking by Market Size (US$ Million) in 2021
Figure 17. Global Multiple Sclerosis Therapeutics Market Share by Players in 2021
Figure 18. Global Top Multiple Sclerosis Therapeutics Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Multiple Sclerosis Therapeutics as of 2021)
Figure 19. The Top 10 and 5 Players Market Share by Multiple Sclerosis Therapeutics Revenue in 2021
Figure 20. North America Multiple Sclerosis Therapeutics Revenue Market Share by Company in 2021
Figure 21. North America Multiple Sclerosis Therapeutics Revenue Market Share by Type (2017-2028)
Figure 22. North America Multiple Sclerosis Therapeutics Revenue Market Share by Distribution Channel (2017-2028)
Figure 23. North America Multiple Sclerosis Therapeutics Revenue Share by Country (2017-2028)
Figure 24. U.S. Multiple Sclerosis Therapeutics Revenue (2017-2028) & (US$ Million)
Figure 25. Canada Multiple Sclerosis Therapeutics Revenue (2017-2028) & (US$ Million)
Figure 26. Europe Multiple Sclerosis Therapeutics Revenue Market Share by Company in 2021
Figure 27. Europe Multiple Sclerosis Therapeutics Revenue Market Share by Type (2017-2028)
Figure 28. Europe Multiple Sclerosis Therapeutics Revenue Market Share by Distribution Channel (2017-2028)
Figure 29. Europe Multiple Sclerosis Therapeutics Revenue Share by Country (2017-2028)
Figure 30. Germany Multiple Sclerosis Therapeutics Revenue (2017-2028) & (US$ Million)
Figure 31. France Multiple Sclerosis Therapeutics Revenue (2017-2028) & (US$ Million)
Figure 32. U.K. Multiple Sclerosis Therapeutics Revenue (2017-2028) & (US$ Million)
Figure 33. Italy Multiple Sclerosis Therapeutics Revenue (2017-2028) & (US$ Million)
Figure 34. Russia Multiple Sclerosis Therapeutics Revenue (2017-2028) & (US$ Million)
Figure 35. Asia Pacific Multiple Sclerosis Therapeutics Revenue Market Share by Company in 2021
Figure 36. Asia Pacific Multiple Sclerosis Therapeutics Revenue Market Share by Type (2017-2028)
Figure 37. Asia Pacific Multiple Sclerosis Therapeutics Revenue Market Share by Distribution Channel (2017-2028)
Figure 38. Asia Pacific Multiple Sclerosis Therapeutics Revenue Share by Region (2017-2028)
Figure 39. China Multiple Sclerosis Therapeutics Revenue (2017-2028) & (US$ Million)
Figure 40. Japan Multiple Sclerosis Therapeutics Revenue (2017-2028) & (US$ Million)
Figure 41. South Korea Multiple Sclerosis Therapeutics Revenue (2017-2028) & (US$ Million)
Figure 42. India Multiple Sclerosis Therapeutics Revenue (2017-2028) & (US$ Million)
Figure 43. Australia Multiple Sclerosis Therapeutics Revenue (2017-2028) & (US$ Million)
Figure 44. Taiwan Multiple Sclerosis Therapeutics Revenue (2017-2028) & (US$ Million)
Figure 45. Indonesia Multiple Sclerosis Therapeutics Revenue (2017-2028) & (US$ Million)
Figure 46. Thailand Multiple Sclerosis Therapeutics Revenue (2017-2028) & (US$ Million)
Figure 47. Malaysia Multiple Sclerosis Therapeutics Revenue (2017-2028) & (US$ Million)
Figure 48. Philippines Multiple Sclerosis Therapeutics Revenue (2017-2028) & (US$ Million)
Figure 49. Vietnam Multiple Sclerosis Therapeutics Revenue (2017-2028) & (US$ Million)
Figure 50. Latin America Multiple Sclerosis Therapeutics Revenue Market Share by Company in 2021
Figure 51. Latin America Multiple Sclerosis Therapeutics Revenue Market Share by Type (2017-2028)
Figure 52. Latin America Multiple Sclerosis Therapeutics Revenue Market Share by Distribution Channel (2017-2028)
Figure 53. Latin America Multiple Sclerosis Therapeutics Revenue Share by Country (2017-2028)
Figure 54. Mexico Multiple Sclerosis Therapeutics Revenue (2017-2028) & (US$ Million)
Figure 55. Brazil Multiple Sclerosis Therapeutics Revenue (2017-2028) & (US$ Million)
Figure 56. Argentina Multiple Sclerosis Therapeutics Revenue (2017-2028) & (US$ Million)
Figure 57. Middle East and Africa Multiple Sclerosis Therapeutics Revenue Market Share by Company in 2021
Figure 58. Middle East and Africa Multiple Sclerosis Therapeutics Revenue Market Share by Type (2017-2028)
Figure 59. Middle East and Africa Multiple Sclerosis Therapeutics Revenue Market Share by Distribution Channel (2017-2028)
Figure 60. Middle East and Africa Multiple Sclerosis Therapeutics Revenue Share by Country (2017-2028)
Figure 61. Turkey Multiple Sclerosis Therapeutics Revenue (2017-2028) & (US$ Million)
Figure 62. Saudi Arabia Multiple Sclerosis Therapeutics Revenue (2017-2028) & (US$ Million)
Figure 63. U.A.E Multiple Sclerosis Therapeutics Revenue (2017-2028) & (US$ Million)
Figure 64. Novartis Revenue Growth Rate in Multiple Sclerosis Therapeutics Business (2017-2022)
Figure 65. Teva Pharmaceuticals Revenue Growth Rate in Multiple Sclerosis Therapeutics Business (2017-2022)
Figure 66. Sanofi Genzyme Revenue Growth Rate in Multiple Sclerosis Therapeutics Business (2017-2022)
Figure 67. Bayer Revenue Growth Rate in Multiple Sclerosis Therapeutics Business (2017-2022)
Figure 68. Pfizer Revenue Growth Rate in Multiple Sclerosis Therapeutics Business (2017-2022)
Figure 69. Biogen Idec Revenue Growth Rate in Multiple Sclerosis Therapeutics Business (2017-2022)
Figure 70. Merck Revenue Growth Rate in Multiple Sclerosis Therapeutics Business (2017-2022)
Figure 71. AbbVie Revenue Growth Rate in Multiple Sclerosis Therapeutics Business (2017-2022)
Figure 72. Bottom-up and Top-down Approaches for This Report
Figure 73. Data Triangulation
Figure 74. Key Executives Interviewed